Geron Corporation (NASDAQ: GERN) Shares Jump on FDA Ruling: U.S. Daily Market Movers

Published:

Small cap
stocks making big moves on Monday, November 03, 2014 (as of 4 pm EST), as
reported by Hassan Malik, SmallCapPower.com

Geron Corporation (NASDAQ: GERN) shares
surged 26% to $2.80 on Monday after the FDA removed its full clinical hold on
the company’s investigational new drug application for imetelstat. The FDA
reported that the development plan put forth by Geron for the treatment of
high-risk myeloid malignancies is acceptable.

As well,
shares of ANI Pharmaceuticals, Inc.
(NASDAQ: ANIP) shot up 21%
to $41.20 following a positive Q3 earnings report. The drug maker reported a
profit of $6.7 million in Q3. On a per-share basis, a profit of 59 cents was
reported. Earnings adjusted for stock option expense came at 66 cents per
share. The company also posted total revenue of $17.4 million for the period.

Federated National Holding Company (NASDAQ: FNHC) stock,
meanwhile, sank 9% to $30.41. Although the slump is disappointing, what is
peculiar about FNHC is its overall appeal within investment advisors. Zacks
Investment ranks the company at a #3 hold. The insurance company has seen 1
positive revision and its current year earnings consensus has moved higher over
the past few weeks. This suggests that the recent slump might be a temporary
blip on the radar for FNHC.  

Related articles

Recent articles